Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{185294,
        author = {Dr.R.Meena Sudhanvi and Dr.G.Srinivas},
        title = {A CASE OF BURKHOLDERIA CEPACIAE IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS INDIVIDUAL},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {5},
        pages = {616-617},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=185294},
        abstract = {Background: Burkholderia cepacia is an aerobic, motile, opportunistic Gram-negative bacillus, notorious for its multidrug resistance and association with nosocomial infections, especially in immunocompromised individuals.
Case Presentation: We report a 28-year-old male with newly diagnosed type 2 diabetes mellitus (HbA1c: 13.4%) who presented with a thigh abscess and high-grade fever. Culture of aspirated pus grew Burkholderia cepacia, susceptible to meropenem, cotrimoxazole, and ceftazidime. The patient responded well to meropenem and cotrimoxazole, with significant clinical improvement, and was discharged on oral cotrimoxazole.
Conclusion: B. cepacia infection, although rare outside cystic fibrosis or chronic granulomatous disease, can complicate diabetes mellitus. Awareness and prompt antimicrobial therapy are essential to reduce morbidity and prevent recurrence.},
        keywords = {Burkholderia cepacia, diabetes mellitus, nosocomial infection, multidrug resistance, case report},
        month = {October},
        }